Registration, booking, home sample collection, specimen tracking, lab process visibility, AI-assisted interpretation for clinician review, plain-language reports, delivery, and analytics across every branch. Where a step touches a clinical judgment, a qualified clinician is at the end of it — by design.
A specimen is registered, collected, transported, run, verified, reported, delivered, and — sometimes — acted upon. Nine steps, and the analyzer accounts for one of them.
The time a diagnostic center loses, and the risk it carries, sits in the handovers: the sample whose identity was re-keyed, the verified result waiting on someone to read it, the critical value that reached an inbox nobody was watching, the report a patient could not understand and therefore did not act on.
CareTech runs the handovers. The analysis stays where it belongs — with the instrument, the method and the qualified person who signs the result.
How we think about trustAnalytics and AI assistance produce indicators (a draft, a flag, a shortlist, a comparison) with the underlying data and the basis shown alongside. They do not diagnose, decide or release — the interpretation of record belongs to the qualified clinician who reviews the draft.
From instrument to audit. The intelligence layer stops at an indicator and a qualified clinician decides.
Specimen 4471-B walks the ten steps above, and the intelligence layer's working is shown as it happens, beside the one stop where everything waits for a person.
Each of the six below is regulated-adjacent in India, the United States, or both. Scope in each market is set with your regulatory counsel before a line is written, and where a feature would fall inside a medical-device definition it is not built until counsel has said so in writing.
Most of what a diagnostic center does is logistics, and logistics is where software helps without standing anywhere near a clinical decision. CareTech runs these six to a center's own process rather than to a template.
Patient registration, test and package booking, appointment scheduling, and home sample collection coordination held in one place rather than three books.
Collection, labeling and chain of custody, so a sample's identity is captured once and carried forward instead of re-keyed at each bench.
Where a sample is, how long it has been there, and which step it is waiting on. Turnaround time becomes a measurement rather than an impression.
Approved reports delivered to the patient and the referring doctor through the channels a center already uses: mobile-friendly, in the languages the center serves, with a record of what was sent and when.
Referring-doctor records, their patients' reports, the communication between the two, and referral source performance: the relationship most diagnostic centers run on and few of them can see.
Test volume, turnaround time, utilization, sample rejection rate and location-by-location comparison for a chain: operational figures, measured against the group's own definitions.
Where a feature would fall inside a medical-device definition, it is not built until counsel has said so in writing. That is a policy, and it holds in every market.
Which reference intervals govern, by assay, age and sex: configured by the center, applied before a clinician's queue is built.
Which results the center defines as critical, who is accountable for acting on them, and how acknowledgment is recorded.
Laboratory, imaging and record integrations: scoped, agreed and built per deployment, against LIS, RIS, PACS, DICOM and HL7- or FHIR-based interfaces.
Every approved report carries the name of the qualified clinician who released it, and the audit record shows what they were shown.
Five questions that decide whether a diagnostic platform runs the center or just stores its results.